- Home
- AKRO vs RUSHA Comparison
AKRO vs RUSHA Comparison
Compare AKRO & RUSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- RUSHA
- Stock Information
- Founded
- AKRO 2017
- RUSHA 1965
- Country
- AKRO United States
- RUSHA United States
- Employees
- AKRO N/A
- RUSHA N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- RUSHA Retail-Auto Dealers and Gas Stations
- Sector
- AKRO Health Care
- RUSHA Consumer Discretionary
- Exchange
- AKRO Nasdaq
- RUSHA Nasdaq
- Market Cap
- AKRO 3.5B
- RUSHA 4.2B
- IPO Year
- AKRO 2019
- RUSHA 1996
- Fundamental
- Price
- AKRO $40.48
- RUSHA $53.41
- Analyst Decision
- AKRO Strong Buy
- RUSHA Buy
- Analyst Count
- AKRO 9
- RUSHA 2
- Target Price
- AKRO $76.29
- RUSHA $64.50
- AVG Volume (30 Days)
- AKRO 938.9K
- RUSHA 381.0K
- Earning Date
- AKRO 05-09-2025
- RUSHA 04-22-2025
- Dividend Yield
- AKRO N/A
- RUSHA 1.34%
- EPS Growth
- AKRO N/A
- RUSHA N/A
- EPS
- AKRO N/A
- RUSHA 3.72
- Revenue
- AKRO N/A
- RUSHA $7,804,746,000.00
- Revenue This Year
- AKRO N/A
- RUSHA $5.26
- Revenue Next Year
- AKRO N/A
- RUSHA $6.34
- P/E Ratio
- AKRO N/A
- RUSHA $14.40
- Revenue Growth
- AKRO N/A
- RUSHA N/A
- 52 Week Low
- AKRO $17.86
- RUSHA $40.99
- 52 Week High
- AKRO $58.40
- RUSHA $65.43
- Technical
- Relative Strength Index (RSI)
- AKRO 36.69
- RUSHA 41.56
- Support Level
- AKRO $41.84
- RUSHA $52.54
- Resistance Level
- AKRO $45.38
- RUSHA $56.33
- Average True Range (ATR)
- AKRO 1.98
- RUSHA 1.70
- MACD
- AKRO -0.40
- RUSHA 0.13
- Stochastic Oscillator
- AKRO 16.39
- RUSHA 39.54
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About RUSHA Rush Enterprises Inc. Cl A
Rush Enterprises Inc is a full-service, integrated retailer of commercial vehicles and related services. The company operates in a single segment; Truck Segment includes the operation of a network of commercial vehicle dealerships under the name Rush Truck Centers. It sells commercial vehicles manufactured by Peterbilt, International, Hino, Ford, Isuzu, IC Bus, and Blue Bird and also provides one-stop service for the needs of commercial vehicle customers, including retail sales of new and used commercial vehicles, aftermarket parts sales, service and repair facilities, financing, leasing and rental, and insurance products. The company's business is concentrated in the United States and Ontario, Canada commercial vehicle markets and related aftermarkets.